Molecular biology of human oral cancer

Critical Reviews in Oral Biology and Medicine

Volumn 7, Issue 4, 1996, Pages 319-328

  Wong, D T W ^a   Todd, R ^a,b   Tsuji, T ^a   Donoff, R B ^a,b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Molecular biology; oral cancer

Indexed keywords

CANCER RESEARCH; CARCINOGENESIS; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; MOUTH CANCER; ONCOGENE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0030463218     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411960070040201     Document Type: Review

References (117)

1. Aaronson SA (1991). Growth factors and cancer. Science 254:1146-1153.
2. Ahsee KW, Cooke TG, Pickford IR, Soutar D, Balmain A (1994). An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54:1617-1621.
3. Barbacid M (1987). Ras genes. Ann Rev Biochem 56:779-827.
4. Batra SK, Rasheed BK, Bigner SH, Bigner DD (1994). Oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest 71:621-637.
5. Behrens J, Mareel MM, VanRoy FM, Birchmeier W (1989). Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 113:173-185.
6. Berenson JR, Yang J, Mickel RA (1989). Frequent amplification of the bcl-1 locus in head and neck squamous cell carconomas. Oncogene 4:1111-1116.
7. Bishop JM (1991). Molecular themes in oncogenesis. Cell 64:235-248.
8. Bookstein R, Lee W-H (1991). Molecular genetics of the retinoblastoma suppressor gene. Crit Rev Oncol 2:211-227.
9. Boring CC, Squires TS, Tong T (1992). Cancer statistics, 1992. CA J Clin Cancer 42:19-38.
10. Bos JL (1989). ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
11. Boveri T (1914). Zur frage der entstehung maligner tumoren. Jena: Gustav Fischer.
12. Boyd NM, Reade PC (1988). Mechanisms of carcinogenesis with particular reference to the oral mucosa. J Oral Pathol 17:193-201.
13. Brandama JL, Abramson AL (1989). Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115:621-625.
14. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ (1995). Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332:712-717.
15. Brenner SE, Pajak TF, Lippman SM, Earley C, Hong WK (1994). Prevention of second primary tumors with isotretinoin in patients with squamous cell carinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 86:140-141.
16. Callender T, El-Nagger AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG (1994). PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carinoma. Cancer 74:152-158.
17. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapaller R (1991). Oncogenes and signal transduction. Cell 64:281-302.
18. Chang LC, Chou MY, Chow P, Matossian K, McBride J, Chiang T (1989). Detection of transforming growth factor-alpha messenger RNA in normal and chemically transformed hamster oral epithelium by in situ hybridization. Cancer Res 49:6700-6707.
19. Chang SE, Bhatia P, Johnson NW, Morgan PR, McCormick F, Young B (1991). Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer 48:409-412.
20. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P (1993). Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas. J Pathol 169:323-328.
21. Coffey RJJ, Meise KS, Matsui Y, Hogan BL, Dempsey PJ, Halter SA (1994). Acceleration of mammary neoplasia in transforming growth factor α transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res 54:1678-1683.
22. Cooper GM (1995). Oncogenes. Cooper GM, editor. Boston: Jones and Bartlett Publishers.
23. DeLuca LM (1991). Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5:2924-2933.
24. Derynck R (1992). The physiology of transforming growth factor-alpha. Adv Cancer Res 58:27-52.
25. Di Fiore PP, Pierce JH, Fleming T, Hazan R, Ullrich A, King CR (1987). Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH-3T3 cells. Cell 51:1063-1070.
26. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA (1989). Autocrine interaction between TGF-α and the EGF-receptor quantitative requirements for induction of the malignant phenotype. Oncogene 4:831-838.
27. Downward J, Yarden Y, Mayes E, Scrace G, Totty J, Stockwell P (1984). Close similarity of epidermal growth factor-receptor and v-erb B oncogene protein sequences. Nature 307:521-527.
28. Dyson N, Howley PM, Munger K, Harlow E (1989). The human papillomavirus 16 E7 oncoprotein is able to bind to retinoblastoma gene product. Science 243:934-937.
29. Elovic A, Galli SJ, Weller PF, Chang AL, Chiang T, Chou MY (1990). Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol 137:1425-1434.
30. Field JK (1992). Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer (B): Oral Oncol 28:67-76.
31. Franceschi S, Gloghini A, Maestro R, Barzan L, Bidoli E, Talamini R (1995). Analysis of the p53 gene in relation to tobacco and alcohol in cancers of the upper aero-digestive tract. Int J Cancer 60:872-876.
32. Good DJ, Polverini PJ, Rastinejad F, Le BM, Lemons RS, Frazier WA (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628.
33. Gordon HM, Kucera G, Salvo R, Boss JM (1992). Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts. J Immunol 148:4021-4027.
34. Grandis JR, Tweardy DJ (1993). Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579-3584.
35. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
36. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H (1991). Identification and characterization of the familial adenomatous polyposis gene. Cell 66:589-600.
37. Hartwell LH, Kastan MB (1994). Cell cycle control and cancer. Science 266:1821-1828.
38. Healy TM (1975). The cellular reaction during carcinogenesis: variations in the numbers of mast cells, plasma cells and eosinophils. Irish J Med Sci 144:255-265.
39. Hirano T, Steele PE, Gluckman JL (1991). Low incidence of point mutation at codon 12 of K-ras proto-oncogene in squamous cell carcinoma of the upper aero-digestive tract. Ann Otol Rhinol Laryngol 100:597-599.
40. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991). p53 mutations in human cancers. Science 253:49-53.
41. Howe PH, Draetta G, Leof EB (1991). Transforming growth factor β-1 inhibition of p34 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Molec Cell Biol 11:1185-1194.
42. Howley PM (1991). Role of the human papillomavirus in human cancer. Cancer Res 51:5019-5022.
43. Hunter T (1991). Cooperation between oncogenes. Cell 64:249-270.
44. Husain Z, Fei YB, Roy S, Solt DB, Polverini PJ, Biswas DK (1989). Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis. Proc Natl Acad Sci USA 86:1264-1268.
45. Irish JC (1992). Oncogenes, molecular biology and the head and neck surgeon. J Otolaryngol 21:1-20.
46. Issing WJ, Wustrow TPU, Heppt WJ (1993). Oncogenes related to head and neck cancer. Anticancer Res 13:2541-2552.
47. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT (1990). TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146.
48. Jin Y, Mertens F (1993). Chromosome abnormalities in oral squamous cell carcinomas. Eur J Cancer (B) - Oral Oncol 29:257-263.
49. Kamb A, Gruis NA, Weaverfeldhaus J, Lui QY, Harshman K (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
50. Kim MS, Li SL, Bertolami CN, Cherrick HM, Park NH (1993). State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res 13:1405-1413.
51. Knudson A (1977). Genetics and the etiology of human cancer. Adv Hum Genet 8:1-66.
52. Kwong YY, Husain Z, Biswas DK (1992). c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis. Oncogene 7:1481-1489.
53. Langdon JD, Partridge M (1992). Expression of the tumor suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg 30:214-220.
54. Largey JS, Meltzer SJ, Yin J, Norris K, Sauk JJ, Archibald DW (1993). Loss of heterozygosity of p53 in oral cancer demonstrated by the polymerase chain reaction. Cancer 71:1933-1937.
55. Lee WH (1993). Tumor suppressor genes - the hope (editorial). FASEB J 7:819.
56. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL (1994). Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54:3662-3667.
57. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ (1995). Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 332:1405-1410.
58. Lund VJ, Howard DJ (1990). Head and neck cancer in the young: a prognostic conundrum? J Laryngol Otol 104:544-548.
59. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ (1990). Development of mammary hyperplasia and neoplasia in MMTV-TGF-α transgenic mice. Cell 61:1147-1155.
60. Merritt WF, Weissler MC, Turk BF, Gilmer TM (1990). Oncogene amplification in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 116:1394-1398.
61. Moroco JR, Solt DB, Polverini PJ (1990). Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab Invest 63:298-306.
62. Moses JL, Yang EY, Pietenpol JA (1990). TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247.
63. Nawroz H, van der Riet P, Hruban RH, Kock WM, Ruppert JM, Sidransky D (1994). Allelotype of head and neck squamous cell carcinoma. Cancer Res 54:1152-1155.
64. Owens GP, Cohen JJ (1992). Identification of genes involved in programmed cell death (review). Cancer & Metastasis Rev 11:149-156.
65. Owens W, Field JK, Howard PJ, Stell PM (1992). Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck. Eur J Cancer (B), Oral Oncol 1:17-21.
66. Park N-H, Min B-M, Li S-L, Huan MZ, Cherrick HM, Doniger J (1991). Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1:1627-1631.
67. Parkin DM, Laara E, Muir CS (1988). Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197.
68. Partridge M, Gullick WJ, Langdon JD, Sheriff M (1988). Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 26:381-389.
69. Partridge M, Kiguwa S, Langdon JD (1994). Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Eur J Cancer (B), Oral Oncol 30:248-251.
70. Polverini PJ (1995). The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6:230-247.
71. Rastinejad F, Polverini PJ, Bouck NP (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355.
72. Rikimaru K, Tadokoro K, Yamamoto T, Enomoto S, Tsuchida N (1992). Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. Head Neck 14:8-13.
73. Riviere A, Spandidos DA, Stell PM, Vaughn ED, Evan GI, Moore JP (1990). Expression of c-erb-B-2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. J Oral Pathol Med 19:408-413.
74. Rumsby G, Carter RL, Gusterson BA (1990). Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 61:365-368.
75. Sacchi M, Kaplan I, Johnson JT, Whiteside TL (1991). Antiproliferative effects of cytokines on squamous cell carcinoma. Arch Otolaryngol. Head Neck Surg 117:321-326.
76. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC (1990). Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121-1135.
77. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Molec Cell Biol 13:320-330.
78. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O (1991). Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13:132-139.
79. Saranath D, Chang SE, Bhoite LT, Panchal RG, Kerr IB, Mehta AR (1991). High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63:573-578.
80. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi VD, Deo MG (1992). Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Eur J Cancer (B) Oral Oncol 28:139-143.
81. Schantz SP (1993). Carcinogenesis, markers, staging, and prognosis of head and neck cancer. Curr Opin Oncol 5:483-490.
82. Schantz SP (1995). Basic science advances in head and neck oncology: the past decade. Sem Surg Oncol 11:272-279.
83. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-36.
84. Scully C (1993). Oncogenes, tumor suppressors and viruses in oral squamous carcinoma. J Oral Pathol Med 22:337-347.
85. Serrano M, Hannon GJ (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
86. Sheng ZM, Barrois M, Klijanienko J, Micheau C, Richard JM, Riou G (1990). Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer 62:398-404.
87. Shields SP, Harris CC (1991). Molecular epidemiology and the genetics of environmental cancer. J Am Med Assoc 266:681-687.
88. Shih C, Padhy LC, Murray M, Weinberg RA (1981). Transforming genes of carcinomas and neuroblastoma introduced mouse fibroblasts. Nature 290:261-264.
89. Shih TY, Papageorge AG, Stokes PE, Weeks MO, Scolnick EM (1980). Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus. Nature 287:686-691.
90. Shillitoe EJ, Lapeyre JN, Adler-Storthz K (1994). Gene therapy - its potential in the management of oral cancer. Eur J Cancer (B) Oral Oncol 30:143-154.
91. Shin DM, Gimenez IB, Lee JS, Nishioka K, Wargovich MJ, Thacher S (1990). Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model. Cancer Res 50:2505-2510.
92. Sidransky D (1995). Molecular genetics of head and neck cancer. Curr Opin Oncol 7:229-233.
93. Sidransky D, Boyle J, Koch W (1993). Molecular screening: prospects for a new approach. Arch Otolaryngol Head Neck Surg. 119:1187-1190.
94. Silverman SJ (1988). Early diagnosis of oral cancer. Cancer 62:1796-1769.
95. Silverman SJ, Gorsky M (1990). Epidemiologic and demographic update in oral cancer: California and national data - 1973 to 1985. J Am Dent Assoc 120:495-499.
96. Somers KD, Cartwright SL, Schechter GL (1990). Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 5:915-920.
97. Spandidos DA, Lamothe A, Field JK (1985). Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumors. Anticancer Res 5:221-224.
98. Sporn MB, Todaro GJ (1980). Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878-880.
99. Stanbridge EJ (1981). Specific chromosomal loss associated with the expression of tumorigenicity in human cell hybrids. Somat Cell Molec Genet 7:699-712.
100. Steele C, Shillitoe EJ (1991). Viruses and oral cancer. Crit Rev Oral Biol Med 2:153-175.
101. Todd R, Donoff RB, Gertz R, Chang AL, Chow P, Matossian K (1989). TGF-alpha and EGF-receptor mRNAs in human oral cancers. Carcinogenesis 10:1553-1556.
102. Todd R, Chou MY, Matossian K, Gallagher GT, Donoff RB, Wong DTW (1991). Cellular sources of transforming growth factor-alpha in human oral cancer. J Dent Res 70:917-923.
103. Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY (1995). Deleted in Oral Cancer-1 (doc-1), a candidate oral cancer suppressor gene. FASEB J 9:1362-1370.
104. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gary A, Tam AW (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425.
105. Van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino T, Koch W (1994). Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156-1158.
106. Vogelstein B, Kinzler KW (1993). The multistep nature of cancer. Trends Genet 9:138-141.
107. Yokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993). Head and neck cancer (review). New Engl J Med 328:184-194.
108. Weiner T, Cance WG (1994). Molecular mechanisms involved in tumorigenesis and their surgical implications. Am J Surg 167:428-434.
109. Wells A, Bishop JM, Helmeste D (1988). Amplified gene for the epidermal growth factor receptor in a human glioblastoma cell line encodes an enzymatically inactive protein. Molec Cell Biol 8:4561-4565.
110. Werness BA, Levine AJ, Howley PM (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
111. Wong DTW, Biswas DK (1987). Expression of c-erb B proto-oncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch. Oncogene 2:67-72.
112. Wong DTW, Gallagher GT, Gertz R, Chang ALC, Shklar G (1988). Transforming growth factor-α in chemically transformed hamster oral keratinocytes. Cancer Res 48:3130-3134.
113. Wong DTW, Gertz R, Chow P, Chang ALC, McBride J, Chiang T (1989). Detection of Ki-ras messenger RNA in normal and chemically transformed hamster oral keratinocytes. Cancer Res 49:4562-4567.
114. Wong DTW, Weller PF, Galli SJ, Elovic A, Rand TH, Gallagher GT (1990). Human eosinophils express transforming growth factor alpha. J Exp Med 172:673-681.
115. Yeudall WA (1992). Human papillomaviruses and oral neoplasia. Eur J Cancer (B) Oral Oncol 28:61-66.
116. Yokota J, Sugimura T (1993). Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 7:920-925.
117. zur Hausen H (1991). Viruses in human cancers. Science 254:1167-1173.